XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis
2010 ◽
Vol 28
(15_suppl)
◽
pp. 3541-3541
◽
Keyword(s):
2014 ◽
Vol 32
(15_suppl)
◽
pp. 3534-3534
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. TPS3639-TPS3639
Keyword(s):
Keyword(s):
2012 ◽
Vol 30
(15)
◽
pp. 1755-1762
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3517-3517
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3517-3517
◽
Keyword(s):
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3516-3516
◽
Keyword(s):